retatrutide effects clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Unapproved weight loss drug retatrutide

The full maintenance dose is not reached until approximately week 17 for the 12 mg regimen

Some of the common ones are: Nausea Headache Stomach pain Heartburn Dizziness Mood changes Experts say its important for people prescribed GLP-1 medications to recognize that the drugs are part of a long-term treatment plan that involves lifestyle factors such as a balanced, healthy diet and regular aerobic and strength exercise

Most Canadians dont eat enough fibre, yet its one of the most powerful nutrients for improving fullness, blood sugar control, digestive health, and long-term metabolic health

avoid trigger foods

I DO NOT recommend anything I havent personally researched inside and out

What matters, however, is what management can forecast with confidence and what it cannot